Zobrazeno 1 - 10
of 210
pro vyhledávání: '"Shigemitsu Takashima"'
Autor:
Fumikata Hara, Sachiko Kiyoto, Daisuke Takabatake, Seiki Takashima, Kenjiro Aogi, Shozo Ohsumi, Norihiro Teramoto, Rieko Nishimura, Shigemitsu Takashima
Publikováno v:
Case Reports in Oncology, Vol 3, Iss 2, Pp 137-141 (2010)
It is well-known that tamoxifen increases the risk of endometrial cancer. Although metastasis to the uterus from breast cancer is uncommon, there have been some case reports on uterine metastasis. If an endometrial abnormality is detected, the differ
Externí odkaz:
https://doaj.org/article/649a35c69602498b97b076a0f4b482cb
Autor:
Fumikata Hara, Sachiko Kiyoto, Daisuke Takabatake, Seiki Takashima, Kenjiro Aogi, Shozo Ohsumi, Norihiro Teramoto, Rieko Nishimura, Shigemitsu Takashima
Publikováno v:
Case Reports in Oncology, Vol 3, Iss 2, Pp 142-147 (2010)
Breast cancer metastases to the stomach are very rare. As characteristics of breast cancer metastases to the stomach, metastases of lobular carcinoma, mainly with signet ring cells, are frequently observed, and they are often difficult to distinguish
Externí odkaz:
https://doaj.org/article/259e0c90a4e048a489d853fb261ff1d0
Autor:
Masahiro Kashiwaba, Hiroyoshi Doihara, Yoshiaki Rai, Kazumitsu Kanatani, Shintaro Takao, Yoshinori Ito, Shigemitsu Takashima, Norikazu Masuda
Publikováno v:
Japanese Journal of Clinical Oncology. 46:407-414
Objective Trastuzumab emtansine significantly improved progression-free survival and overall survival when compared with lapatinib-capecitabine in pretreated human epidermal growth factor receptor 2-positive advanced breast cancer. However, data in J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e73d236b5fff56e612fbef56e0b8611
https://doi.org/10.1093/jjco/hyw013
https://doi.org/10.1093/jjco/hyw013
Autor:
K. Ishida, T. Osako, M. Tsuneizumi, Masato Takahashi, Tsutomu Takashima, Yoshihumi Komoike, S. Matsumoto, Shigemitsu Takashima, Yoshinori Ito, D. Shimizu, M. Yamaguchi, Tomio Nakayama, Noriyuki Masuda, Shoichiro Ohtani, S. Nagai, T. Asakawa, Masahiko Ikeda
Publikováno v:
Annals of Oncology. 30:v127-v128
Background CLEOPATRA study demonstrated the efficacy and safety of pertuzumab (P) + trastuzumab (T) + docetaxel (D) but efficacy results of Japanese subgroup weren't consistent with the whole study results. A phase IV, multicenter, prospective, COMAC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a45f38728167d44ff4164cd4c78de23
https://doi.org/10.1093/annonc/mdz242.048
https://doi.org/10.1093/annonc/mdz242.048
Autor:
Shigemitsu Takashima, Masaaki Kataoka, Naomi Nakajima, Shozo Ohsumi, Yasushi Hamamoto, Syuichi Shinohara, Kenjiro Aogi
Publikováno v:
Breast Cancer. 21:177-182
To define the factors associated with increased risk of isolated locoregional failure that may justify postmastectomy radiotherapy in patients with T1/2 breast cancer and 1–3 positive lymph nodes. Between 1990 and 2002, 248 patients who had pT1–2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::888c1c0ef70bee21b51214082c464647
https://doi.org/10.1007/s12282-012-0369-7
https://doi.org/10.1007/s12282-012-0369-7
Autor:
Naomi Nakajima, Yasushi Hamamoto, Kenjiro Aogi, Shozo Ohsumi, Masaaki Kataoka, Shigemitsu Takashima, Shuich Shinohara
Publikováno v:
Breast Cancer. 20:247-253
The impact of aggregate of risk factors on isolated locoregional failure after mastectomy without radiotherapy was assessed.We reviewed 1091 patients who had stage I-III unilateral breast cancer and received mastectomy between 1990 and 2002.Median fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d1f29831ecf11de4c982bbc93bc19ba
https://doi.org/10.1007/s12282-012-0335-4
https://doi.org/10.1007/s12282-012-0335-4
Autor:
Shozo Ohsumi, Yasushi Hamamoto, Shuichi Shinohara, Naomi Nakajima, Kenjiro Aogi, Shigemitsu Takashima, Masaaki Kataoka
Publikováno v:
Breast Cancer. 20:218-222
There is still controversy concerning the indication of postmastectomy radiotherapy (PMRT) for pT3N0M0 breast cancer. To identify the candidates for PMRT in this subset, we investigated failure patterns, and searched for risk factors for isolated loc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb5996daabf0360d67ed5690ba0911e5
https://doi.org/10.1007/s12282-011-0331-0
https://doi.org/10.1007/s12282-011-0331-0
Autor:
Kenjiro Aogi, Shunji Kamigaki, Masahiro Kashiwaba, Yasuhiro Fujiwara, Shigemitsu Takashima, Takashi Oda, Hiroji Iwata, Norikazu Masuda, Shinji Ohno, Yoshinori Ito, Takayuki Ueno
Publikováno v:
Breast Cancer Research and Treatment. 129:829-838
Despite extensive evaluation of first-line bevacizumab-containing therapy in randomized trials in locally recurrent/metastatic breast cancer (LR/mBC), data from Japanese populations are limited. We conducted a phase II study exclusively in Japanese p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::365e6d3df3e707f34e43d913a67101b3
https://doi.org/10.1007/s10549-011-1685-x
https://doi.org/10.1007/s10549-011-1685-x
Autor:
Shintaro Takao, Yutaka Tokuda, Masami Ishii, Shigemitsu Takashima, Jumpei Funai, Toshiaki Saeki
Publikováno v:
Breast Cancer. 19:335-342
Recently gemcitabine has been approved for treatment of metastatic or recurrent breast cancer in Japan; however, no systematically investigated safety study of long-term gemcitabine monotherapy has been reported despite its wide use globally for mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad13642bfc43af1db8ad10aeca4c2a08
https://doi.org/10.1007/s12282-011-0289-y
https://doi.org/10.1007/s12282-011-0289-y
Autor:
Sachiko Kiyoto, Shigemitsu Takashima, Rieko Nishimura, Fumikata Hara, Kenjiro Aogi, Norihiro Teramoto, Shozo Ohsumi, Seiki Takashima, Daisuke Takabatake
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 3, Iss 2, Pp 142-147 (2010)
Case Reports in Oncology, Vol 3, Iss 2, Pp 142-147 (2010)
Breast cancer metastases to the stomach are very rare. As characteristics of breast cancer metastases to the stomach, metastases of lobular carcinoma, mainly with signet ring cells, are frequently observed, and they are often difficult to distinguish
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fac651cff2a2dad19ed7b7a6712b0158
http://europepmc.org/articles/PMC2919990
http://europepmc.org/articles/PMC2919990